Answer
No. It is targeted radionuclide therapy: a receptor-binding molecule carries radioactive lutetium to susceptible tumour cells.
Sources for this answer
- Lutathera 370 MBq/mL solution for infusionemc · SmPC Current selected SmPC · Version 8
loading page…